109 related articles for article (PubMed ID: 32584548)
1. Single Quantum Dot Tracking Unravels Agonist Effects on the Dopamine Receptor Dynamics.
Kovtun O; Torres R; Ferguson RS; Josephs T; Rosenthal SJ
Biochemistry; 2021 Apr; 60(13):1031-1043. PubMed ID: 32584548
[TBL] [Abstract][Full Text] [Related]
2. Biotinylated-spiperone ligands for quantum dot labeling of the dopamine D2 receptor in live cell cultures.
Tomlinson ID; Kovtun O; Crescentini TM; Rosenthal SJ
Bioorg Med Chem Lett; 2019 Apr; 29(8):959-964. PubMed ID: 30808590
[TBL] [Abstract][Full Text] [Related]
3. Alterations in D1/D2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor.
Fetsko LA; Xu R; Wang Y
Brain Res; 2003 Mar; 967(1-2):191-200. PubMed ID: 12650980
[TBL] [Abstract][Full Text] [Related]
4. Agonist and antagonist effects of aripiprazole on D₂-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone.
Ma GF; Raivio N; Sabrià J; Ortiz J
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522390
[TBL] [Abstract][Full Text] [Related]
5. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum.
Centonze D; Gubellini P; Usiello A; Rossi S; Tscherter A; Bracci E; Erbs E; Tognazzi N; Bernardi G; Pisani A; Calabresi P; Borrelli E
Neuroscience; 2004; 129(1):157-66. PubMed ID: 15489038
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.
Lindgren N; Usiello A; Goiny M; Haycock J; Erbs E; Greengard P; Hokfelt T; Borrelli E; Fisone G
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4305-9. PubMed ID: 12651945
[TBL] [Abstract][Full Text] [Related]
7. Absence of D2S dopamine receptor in the prolactin-secreting MMQ pituitary clone: characterization of a wild D2L receptor coupled to native transduction mechanisms.
Ventra C; Meucci O; Grimaldi M; Scorziello A; Porcellini A; Schettini G
J Mol Endocrinol; 1995 Jun; 14(3):375-89. PubMed ID: 7669227
[TBL] [Abstract][Full Text] [Related]
8. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
Boundy VA; Pacheco MA; Guan W; Molinoff PB
Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced up-regulation of dopamine D2 receptors on cultured cells.
Starr S; Kozell LB; Neve KA
J Neurochem; 1995 Aug; 65(2):569-77. PubMed ID: 7616211
[TBL] [Abstract][Full Text] [Related]
10. Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer.
Gazi L; López-Giménez JF; Rüdiger MP; Strange PG
Eur J Biochem; 2003 Oct; 270(19):3928-38. PubMed ID: 14511374
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
Watts VJ; Neve KA
Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
[TBL] [Abstract][Full Text] [Related]
12. Chronic activation of the D2 dopamine autoreceptor inhibits synaptogenesis in mesencephalic dopaminergic neurons in vitro.
Fasano C; Poirier A; DesGroseillers L; Trudeau LE
Eur J Neurosci; 2008 Oct; 28(8):1480-90. PubMed ID: 18973573
[TBL] [Abstract][Full Text] [Related]
13. Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.
Mottola DM; Kilts JD; Lewis MM; Connery HS; Walker QD; Jones SR; Booth RG; Hyslop DK; Piercey M; Wightman RM; Lawler CP; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 2002 Jun; 301(3):1166-78. PubMed ID: 12023552
[TBL] [Abstract][Full Text] [Related]
14. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone.
Wang S; Che T; Levit A; Shoichet BK; Wacker D; Roth BL
Nature; 2018 Mar; 555(7695):269-273. PubMed ID: 29466326
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.
Leysen JE; Gommeren W; Mertens J; Luyten WH; Pauwels PJ; Ewert M; Seeburg P
Psychopharmacology (Berl); 1993; 110(1-2):27-36. PubMed ID: 7870895
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.
Wang Y; Xu R; Sasaoka T; Tonegawa S; Kung MP; Sankoorikal EB
J Neurosci; 2000 Nov; 20(22):8305-14. PubMed ID: 11069937
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
Vortherms TA; Watts VJ
J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
[TBL] [Abstract][Full Text] [Related]
18. Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells.
Ng GY; Varghese G; Chung HT; Trogadis J; Seeman P; O'Dowd BF; George SR
Endocrinology; 1997 Oct; 138(10):4199-206. PubMed ID: 9322930
[TBL] [Abstract][Full Text] [Related]
19. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
Prus AJ; Schuck CJ; Rusch KR; Carey LM
Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical regulation of dopamine receptors in transfected 293 cells.
Filtz TM; Artymyshyn RP; Guan W; Molinoff PB
Mol Pharmacol; 1993 Aug; 44(2):371-9. PubMed ID: 8102783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
